Free Trial

Grace Therapeutics (GRCE) Institutional Ownership

Grace Therapeutics logo
$2.94 -0.02 (-0.68%)
As of 06/26/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Grace Therapeutics (NASDAQ:GRCE)

Current
Institutional Ownership
Percentage
6.08%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$4.14M
Number of
Institutional Sellers
(last 12 months)
0
Get GRCE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Grace Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Grace Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025 ADAR1 Capital Management LLC343,512$783K0.1%N/A3.388%
5/15/2025 Nantahala Capital Management LLC1,178,203$2.69M0.1%N/A11.619%
5/14/2025 Stonepine Capital Management LLC294,550$666K0.6%N/A2.905%
(Data available from 1/1/2016 forward)

GRCE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GRCE shares?

During the previous two years, the following institutional investors and hedge funds held shares of Grace Therapeutics shares: Nantahala Capital Management LLC ($2.69M), and ADAR1 Capital Management LLC ($783K), Stonepine Capital Management LLC ($666K).Learn more on Grace Therapeutics' institutional investors.

What percentage of Grace Therapeutics' stock is owned by institutional investors?

6.08% of Grace Therapeutics' stock is owned by institutional investors. Learn more on GRCE's institutional investor holdings.

Which institutional investors have been buying Grace Therapeutics' stock?

The following institutional investors have purchased Grace Therapeutics' stock in the last 24 months: Nantahala Capital Management LLC ($1.18M), ADAR1 Capital Management LLC ($343.51K), and Stonepine Capital Management LLC ($294.55K).

How much institutional buying is happening at Grace Therapeutics?

Institutional investors have bought a total of 1,816,265 shares in the last 24 months. This purchase volume represents approximately $4.14M in transactions.



This page (NASDAQ:GRCE) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners